Results 51 to 60 of about 134,961 (204)

Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection. [PDF]

open access: yes, 2011
<p>Black Aspergilli are widely distributed in the environment and are frequently reported as causative agents of different types of mycoses. Many taxonomical revisions have been made, and presently 19 different species are accepted.
M. Hendrickx, M. Detandt, H. Beguin
core   +1 more source

Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis [PDF]

open access: yes, 2019
Hui-Chen Su,1,* Yi-Ming Hua,1,* I Jung Feng,2 Hung-Chang Wu31Department of Pharmacy, Chi Mei Medical Center, Tainan City, Taiwan; 2Department of Medical Research, Chi Mei Medical Center, Tainan City, Taiwan; 3Division of Hematology-Oncology, Department ...
Feng IJ, Wu HC, Hua YM, Su HC
core  

Update on antifungal agents for paediatric patients [PDF]

open access: yes, 2010
Paediatric age groups display important differences in host biology, predisposing conditions, epidemiology and presentation of fungal infections relative to the adult population.
A.H. Groll   +3 more
core   +1 more source

Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects

open access: yesActa Pharmaceutica Sinica B
Invasive fungal infections (IFIs) have become prominent global health threats, escalating the burden on public health systems. The increasing occurrence of invasive fungal infections is due primarily to the extensive application of chemotherapy ...
Xueni Lu   +9 more
doaj   +1 more source

Genetic Differentiation, Diversity, and Drug Susceptibility of Candida krusei

open access: yesFrontiers in Microbiology, 2018
Candida krusei is a notable pathogenic fungus that causes invasive candidiasis, mainly due to its natural resistance to fluconazole. However, to date, there is limited research on the genetic population features of C. krusei.
Jie Gong   +13 more
doaj   +1 more source

Impact of first-line antifungal agents on the outcomes and costs of candidemia [PDF]

open access: yes, 2012
Candida species are the leading causes of invasive fungal infection among hospitalized patients and are responsible for major economic burdens. The goals of this study were to estimate the costs directly associated with the treatment of candidemia and ...
한상훈
core  

Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days. [PDF]

open access: yes, 2014
Cryptococcal meningoencephalitis is an urgent global health problem. Induction regimens using 14 days of amphotericin B deoxycholate (dAmB) are considered the standard of care but may not be suitable for resource-poor settings.
Sharp, Andrew D   +38 more
core   +1 more source

Resposta in vitro de fungos agentes de micoses cutâneas frente aos antifúngicos sistêmicos mais utilizados na dermatologia In vitro response of cutaneous mycosis fungal agents to the most widely used systemic antifungals in dermatology

open access: yesAnais Brasileiros de Dermatologia, 2009
FUNDAMENTOS - A alta frequência das micoses cutâneas justifica a necessidade de avaliar a possível contribuição da determinação do perfil de susceptibilidade aos antifúngicos in vitro.
Lívia Maria Martins de Almeida   +3 more
doaj   +1 more source

Compare the efficacy of antifungal agents as primary therapy for invasive aspergillosis: a network meta-analysis

open access: yesBMC Infectious Diseases
Background Several antifungal agents are available for primary therapy in patients with invasive aspergillosis (IA). Although a few studies have compared the effectiveness of different antifungal agents in treating IA, there has yet to be a definitive ...
Ao Liu   +6 more
doaj   +1 more source

Antifungal Drugs: Special Problems Treating Central Nervous System Infections

open access: yesJournal of Fungi, 2019
Treating fungal infections in the central nervous system (CNS) remains a challenge despite the availability of new antifungal agents. Therapy is limited by poor understanding of the kinetic properties of antifungal drugs in the CNS compounded by lack of ...
Elizabeth Dodds Ashley
doaj   +1 more source

Home - About - Disclaimer - Privacy